Federal Regulators Abandon Cancer Study of Nuclear Plants

NAS began the study in 2010, and completed the first phase in 2012. The next phase had been underway for about three years when it was halted. The study was to have been an update to a 1990 review conducted by the National Cancer Institute, which analyzed cancer death rates in areas near 52 nuclear plants. That study concluded that there was no increased risk of cancer for people living close to the nuclear facilities.

Xarelto’s “New” Liver Side Effects

News is surfacing that may indicate an additional warning needs to be added to Xarelto’s label. Cases of liver damage in patients taking the drug have been reported. The current warning does not mention liver damage but that information is available through non-manufacturer sites.

FDA Issues Dosing Warning for Collegium’s Experimental Painkiller

Unlike most opioid painkillers, which are either taken on an empty stomach or without regard for food intake, users must take Xtampza after eating to release the maximum effects. The FDA warned that if Xtampza is taken without food, it will lead to inadequate pain control, and contribute to abuse and overdose by users who are seeking to remedy their pain.

Giving OxyContin to 11 Year-Olds

The FDA recently issued guidelines for doctors to use in prescribing OxyContin (oxycodone) to pediatric patients as young as 11 years-old. As could be predicted, the Internet lost its collective mind. Doctors and senators are doing the Kermit arm flail and crying about how the FDA is plotting to turn innocent American youth into strung-out junkies. They’re so uninformed that they don’t even know that docs have been able to prescribe this, and other powerful pain medications, to pediatric patients for years. The FDA guidelines only serve to make such practice safer for all concerned.

Alleged Cover-up Could Blow Roof off of Asbestos Litigation

The appeals ruling involved a class-action suit filed by relatives of alleged asbestos victims who accused BASF and Cahill of a systematic cover-up involving the destruction of key documents involving Engelhard asbestos litigation. Although the case in itself is not injury related, evidence of a cover-up could revive many previously litigated cases and cases in which plaintiffs settled for less than they would have had they attained access to factual information.

Sincerely Nuts Recalls Macadamia Products due to Salmonella Scare

According to the FDA, Persons infected with the salmonella organism “often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain” that in rare circumstances, “can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.”

Appeals Court Rules for Novartis against Amgen in Biosimilar Cancer Treatment Suit

The U.S. Court of Appeals for the Federal Circuit granted a major victory for Novartis AG, the world’s pharmaceutical market leader. The court’s three-judge panel ruled 2-1 on Wednesday, declining a petition to renew a six-month injunction filed by competitor Amgen involving the marketing of a biosimilar drug comparable to Amgen’s breakthrough cancer treatment Neupogen

Michigan Man Injured by Bair Hugger

William L. filed suit against 3M and Arizant Healthcare, Inc. claiming that their Bair Hugger caused him to develop an infection requiring additional surgeries and leaving him with permanent injuries. A patient warmer, the Bair Hugger blows hot air right onto the patient’s exposed skin during surgery.